Missed Endpoints In PIX306 Mean End Of The Line For Pixuvri In NHL
Executive Summary
Pixuvri's failure in a pivotal trial treating aggressive B-cell non-Hodgkin's lymphoma is bad news for Servier and CTI BioPharma and probably means 'end of the line' for their drug.